A species difference in platelet aggregation induced by tumour cells.
Ehrlich ascites tumour cells (EATC) induced the aggregation of human platelets but not of sheep or rabbit platelets in native platelet-rich plasma. Aggregation was initiated by the interaction of EATC with a component(s) of human plasma, possibly related to the complement system, which led to the release of cellular ADP, a potent platelet aggregating agent. EATC previously incubated with human platelet-poor plasma induced immediate aggregation in platelet-rich plasma from all three species. The species difference in platelet aggregation by EATC is therefore related to the activity or availability of plasma component(s) responsible for release of cellular ADP rather than to intrinsic differences in platelet responsiveness to the tumour cells.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000097:blood*; D002478:Cells, Cultured; D006801:Humans; D010974:Platelet Aggregation; D011817:Rabbits; D012756:Sheep / Q000097:blood; D013045:Species Specificity